A2P Stock Overview

Provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. More details

A2P fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	2/6
Past Performance	6/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 50.5% below our estimate of its fair value

Earnings are forecast to grow 14.41% per year

Earnings grew by 61.4% over the past year

Trading at good value compared to peers and industry

Risk Analysis

No risks detected for A2P from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Synektik Spólka Akcyjna Competitors

Nexus

XTRA:NXU

€1.2b

CompuGroup Medical SE KGaA

XTRA:COP

€1.1b

MeVis Medical Solutions

XTRA:M3V

€44.4m

DocCheck

XTRA:AJ91

€38.8m

Price History & Performance

Summary of share price highs, lows and changes for Synektik Spólka Akcyjna
Historical stock prices
Current Share Price	zł43.50
52 Week High	zł46.60
52 Week Low	zł26.00
Beta	1.39
1 Month Change	8.75%
3 Month Change	1.52%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	62.92%

Recent updates

Shareholder Returns

	A2P	DE Healthcare Services	DE Market
7D	-1.2%	1.2%	-2.0%
1Y	n/a	-20.4%	6.9%

Return vs Industry: Insufficient data to determine how A2P performed against the German Healthcare Services industry.

Return vs Market: Insufficient data to determine how A2P performed against the German Market.

Price Volatility

Is A2P's price volatile compared to industry and market?
A2P volatility
A2P Average Weekly Movement	6.1%
Healthcare Services Industry Average Movement	6.0%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: A2P has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: A2P's weekly volatility (6%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2001	164	Cezary Kozanecki	www.synektik.com.pl

Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology.

Synektik Spólka Akcyjna Fundamentals Summary

How do Synektik Spólka Akcyjna's earnings and revenue compare to its market cap?
A2P fundamental statistics
Market cap	€378.99m
Earnings (TTM)	€19.86m
Revenue (TTM)	€146.58m

19.1x

P/E Ratio

2.6x

P/S Ratio

Is A2P overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A2P income statement (TTM)
Revenue	zł624.80m
Cost of Revenue	zł516.98m
Gross Profit	zł107.82m
Other Expenses	zł23.18m
Earnings	zł84.64m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 05, 2025

Earnings per share (EPS)	9.92
Gross Margin	17.26%
Net Profit Margin	13.55%
Debt/Equity Ratio	10.0%

How did A2P perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

33%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 08:37
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Synektik Spólka Akcyjna is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kamil Kliszcz	Biuro maklerskie mBanku
Adrian Kowollik	East Value Research GmbH
Tomasz Sokolowski	Santander Brokerage Poland